CoChat

RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets

Pan, Yang, Kadash-Edmondson, Kathryn E., Wang, Robert, Phillips, John, Liu, Song, Ribas, Antoni, Aplenc, Richard, Witte, Owen N., Xing, Yi · 2021 · Trends in Pharmacological Sciences
Cited by 53

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Abstract

Cancer transcriptomes frequently exhibit RNA dysregulation. As the resulting aberrant transcripts may be translated into cancer-specific proteins, there is growing interest in exploiting RNA dysregulation as a source of tumor antigens (TAs) and thus novel immunotherapy targets. Recent advances in high-throughput technologies and rapid accumulation of multiomic cancer profiling data in public repositories have provided opportunities to systematically characterize RNA dysregulation in cancer and identify antigen targets for immunotherapy. However, given the complexity of cancer transcriptomes and proteomes, important conceptual and technological challenges exist. Here, we highlight the expanding repertoire of TAs arising from RNA dysregulation and introduce multiomic and big data strategies for identifying optimal immunotherapy targets. We discuss extant barriers for translating these targets into effective therapies as well as the implications for future research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tips.2021.01.006

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Ouspenskaia, 2020, Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancer, bioRxiv
  2. Pan, 2019, IRIS: big data-informed discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing, bioRxiv

Cited by

See all 53

Metadata

Authors
Pan, Y., Kadash-Edmondson, K. E., Wang, R., Phillips, J., Liu, S., Ribas, A., Aplenc, R., Witte, O. N., & Xing, Y.
Venue
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Published
2021-04
Volume
42
Issue
4
Pages
268-282
ISSN
0165-6147
Cited by
53
References
93
Language
en
Licence
Funders
  • National Institutes of Health
  • National Cancer Institute (P50CA092131, R01CA220238, U01CA233074, U24CA232979)
  • Parker Institute for Cancer Immunotherapy (20163828)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.